Evidence map›Paper›PMID 27016371›Full record

ArticleCalcified tissue international2016

Regulation of CYP27B1 mRNA Expression in Primary Human Osteoblasts.

K van der Meijden, H W van Essen, F W Bloemers, E A J M Schulten, P Lips, N Bravenboer

Abstract read
In one paragraph

Article in Calcified tissue international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

K van der MeijdenDepartment of Internal Medicine/Endocrinology, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands.
H W van EssenDepartment of Clinical Chemistry, VU University Medical Center, Research Institute MOVE, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
F W BloemersDepartment of Trauma Surgery, VU University Medical Center, Amsterdam, The Netherlands.
E A J M SchultenDepartment of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands.
P LipsDepartment of Internal Medicine/Endocrinology, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands.
N BravenboerDepartment of Clinical Chemistry, VU University Medical Center, Research Institute MOVE, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. n.bravenboer@vumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzyme 1α-hydroxylase (gene CYP27B1) catalyzes the synthesis of 1,25(OH)2D in both renal and bone cells. While renal 1α-hydroxylase is tightly regulated by hormones and 1,25(OH)2D itself, the regulation of 1α-hydroxylase in bone cells is poorly understood. The aim of this study was to investigate in a primary human osteoblast culture whether parathyroid hormone (PTH), fibroblast growth factor 23 (FGF23), calcitonin, calcium, phosphate, or MEPE affect mRNA levels of CYP27B1. Our results show that primary human osteoblasts in the presence of high calcium concentrations increase their CYP27B1 mRNA levels by 1.3-fold. CYP27B1 mRNA levels were not affected by PTH1-34, rhFGF23, calcitonin, phosphate, and rhMEPE. Our results suggest that the regulation of bone 1α-hydroxylase is different from renal 1α-hydroxylase. High calcium concentrations in bone may result in an increased local synthesis of 1,25(OH)2D leading to an enhanced matrix mineralization. In this way, the local synthesis of 1,25(OH)2D may contribute to the stimulatory effect of calcium on matrix mineralization.

Indexed as

25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcitoninCalciumFibroblast Growth Factor-23Fibroblast Growth FactorsGene Expression Regulation, EnzymologicHumansKidneyOsteoblastsParathyroid HormoneRNA, Messenger25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcitoninCalciumFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsParathyroid HormoneRNA, MessengerCalciumCYP27B1Fibroblast growth factor 23Matrix extracellular phosphoglycoproteinParathyroid hormonePrimary human osteoblasts

Identifiers

PMID27016371
PMCPMC4932130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.